Wednesday, 22 May 2019

Drug Discovery News

  • Merck, AstraZeneca sign deal for cancer drug therapy

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2013

    Singapore: Merck and AstraZeneca entered into a licensing agreement for Merck's oral small molecule inhibitor of WEE1 kinase (MK-1775). MK-1775 is currently being evaluated in phase IIa cli...Read more

  • Inversion of ibuprofen in body helps fight cancer: Study

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2013

    Singapore: Scientists at the Department of Pharmacy and Pharmacology, University of Bath, UK, demonstrated that anti-inflammatory drug ibuprofen might stop certain cancers from developing. ...Read more

  • Australia ideal for early-stage drug development

    Drug Discovery |  Opinion | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2012

    Australia has a long history in biomedical research, with a reputation for excellence and invention since the early 1900s. This history includes a notable sprinkling of Nobel Prize winners,...Read more

  • HUYA, Sanzao Park partner for drug development

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: HUYA Bioscience, a leader in globalizing China's biopharmaceutical innovations, has signed a strategic partnership with Zhuhai Sanzao Science and Technology Industrial Park. The ...Read more

  • GSK's cancer drug gets EU marketing authorization

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2013

    Singapore: European Commission has granted an additional indication for GlaxoSmithKline's Tyverb (lapatinib) to be used in combination with trastuzumab. This combination is indicated for a...Read more

  • Astellas completes patient recruitment in drug trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registration study SECURE. Isavuconazole is an investigational intravenous (IV)...Read more

  • Daiichi Sankyo expands drug discovery program

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities and research institutions based in Japan, 'Take a New challenge for Dr...Read more

  • Boehringer terminates insulin deal with Lilly

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

    Singapore: Eli Lilly and Boehringer Ingelheim are making a slight adjustment to their diabetes alliance with respect to LY2605541, Lilly's novel basal insulin analog. Lilly is re-assuming ...Read more

  • Cellmid gets positive sign with Midkine antibody for kidney disease

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Australia's Cellmid has completed its first in-life diabetic nephropathy study with anti-midkine antibodies (MK-Ab) in a mouse model of the disease. Two of Cellmid's proprietary ...Read more

  • Takeda Gemini II trial shows positive results

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase III trial. The trial evaluated v...Read more

  • IOF, Fonterra grants $43K to Indonesian for bone R&D

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

    Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have come together to fund and support research on female bone health in In...Read more

  • Vanda Pharma withdraws application for Fanaptum

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Singapore: Vanda Pharmaceuticals has withdrawn its application from European Medicines Agency for a centralized marketing authorization for the medicine Fanaptum (iloperidone) intended to b...Read more

  • AbbVie invests $320 mn in bilogics manufacturing in Singapore

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Research based pharmaceutical company, AbbVie, has made investment of around USD320 million in Singapore to set up small molecule and biologics active drug substance manufacturin...Read more

  • Prana Alzheimer's trial shows +ve results

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Apr, 2013

    Singapore: Prana Biotechnology reported on the progress of its lead development asset PBT2, which is in phase II trials for Huntington disease and Alzheimer's disease. Across the two trials...Read more

  • Astellas to do interim analysis of cancer trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Apr, 2013

    Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a global phase III clinical trial evaluating Xtandi (enzalutamide) capsule...Read more

  • Novartis acquires cancer firm CoStim

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2014

    Singapore: Global pharmaceutical firm, Novartis, has acquired CoStim Pharmaceuticals, a privately held biotechnology company, broadening its cancer immunotherapy research program. Increasi...Read more

  • Cytos reveals trial data allergic asthma immune modulator

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

    Singapore: Cytos Biotechnology revealed additional results of the phase IIa clinical trial with CYT003, a first-in-class immune modulator in clinical development as a potential new treatmen...Read more

  • Prism to start PRI-724 trials to treat fibrosis

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2013

    Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, announced the close of an approximately $15 m...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls